Comple.med Launches the First Food Supplement in Europe Featuring IMMUSE®
Kyowa Hakko’s IMMUSE®, a clinically researched unique postbiotic, provides immune support in Lactoflor® Immuno 200...
Manufacturing strains of Kyowa Hakko Bio’s 3'-sialyllactose and 6’-sialyllactose, human milk oligosaccharides (HMOs), passed safety evaluation in China
KYOWA HAKKO BIO CO., LTD. (Kyowa Hakko Bio) is pleased to announce that its manufacturing strains used for producing 3'-sialyllactose (3’-SL) and 6’-sialyllactose (6’-SL) have passed the Chinese Ministry of Agriculture and Rural affairs’ (MARA) safety evaluation...
Completion Of Human Milk Oligosaccharides (HMOs) Production Facility
KYOWA HAKKO BIO CO. LTD. (Kyowa Hakko Bio), a subsidiary of Kirin Holdings Company, Limited (Kirin Holdings), completed a production facility for human milk oligosaccharides (HMOs) on November 18, 2022 at its Thai subsidiary, THAI KYOWA BIOTECHNOLOGIES CO., LTD.
Manufacturing strain of Kyowa Hakko Bio’s 2'-fucosyllactose, a human milk oligosaccharide (HMO), passed safety evaluation in China.
KYOWA HAKKO BIO CO., LTD. (Kyowa Hakko Bio) is pleased to announce that its manufacturing strain used for producing 2'-fucosyllactose (2’-FL), the most abundant HMO in human milk, has passed the safety...
Cognizin® Citicoline - NutraIngredients Award Winner Europe 2022
Kyowa Hakko Europe, a leading international health ingredient manufacturer, is pleased to announce this prestigious NutraIngredients Award given to its flagship product Cognizin® Citicoline...
Kyowa Hakko Announces the Appointment of Dr. Colin Hill to the Scientific Advisory Board of Award-Winning Postbiotic IMMUSE™
With an impressive background in mining the microbiome for novel therapies, Prof. Hill helped with the definition of a postbiotic as a part of ISAPP.
New Research Suggests Kyowa Hakko Bio’s Cognizin® Citicoline Aids in Memory Function
Findings published in The Journal of Nutrition demonstrate supplementation of citicoline for improved overall memory performance in healthy elderly populations.
IMMUSE® Enters European Market
Strengthen Your Body’s Defenses from the Inside with IMMUSE®. A patented unique strain of Lactococcus lactis provides a more comprehensive approach to immune support...
Kyowa Hakko Bio Establishes New Facility in Thailand to Supply Human Milk Oligosaccharides Worldwide
KYOWA HAKKO BIO CO. LTD., a subsidiary of Kirin Holdings Company, has announced that it will establish a new facility to manufacture human milk oligosaccharides (HMOs) in Thailand. Kyowa Hakko Bio decided on the move with expectations of a future increase in global demand for HMOs. This move further expands its global footprint to consolidate its position as a global...
When It Comes to Optimal Hydration, the New Go-to is Pro EAA Ice with Sustamine® L-Alanyl-L-Glutamine *
Serious athletes know the key to top performance is hydration. Keeping the body fueled with water and other nutrients can mean the difference between first and second place.